FDA Blocks Mail Distribution of Abortion Pills
A federal appeals court blocked the mailing of mifepristone, a common abortion pill, requiring it to be dispensed in person at clinics. The ruling, issued by the Fifth U.S. Circuit Court of Appeals, cited conflicts with Louisiana's abortion ban. Danco Laboratories, the drug's manufacturer, has appealed the decision to the U.S. Supreme Court.
- ▪A federal appeals court ruled that mifepristone cannot be mailed and must be dispensed in person at clinics.
- ▪The Fifth U.S. Circuit Court of Appeals unanimously decided that mailing the drug undermines Louisiana’s abortion laws.
- ▪Danco Laboratories has appealed the ruling to the U.S. Supreme Court, seeking to overturn the decision.
- ▪The Supreme Court previously ruled unanimously in 2024 against restricting mifepristone, though on technical grounds.
- ▪Mifepristone is the most common method of abortion in the U.S., often prescribed via telehealth and delivered by mail.
Opening excerpt (first ~120 words) tap to expand
Politics FDA Blocks Mail Distribution of Abortion Pills State of the Union: The court ruled that allowing the pills to be mailed undermines the state’s abortion law. (Photo illustration by Anna Moneymaker/Getty Images) <div class="o-image__issue-wrapper"> <img class="o-image__image" srcset="https://tac.imgix.net/wp-content/uploads/2024/08/TAC_jaddinghs_final.jpg?auto=format&crop=faces%2Centropy&fit=crop&ixlib=php-3.3.1&w=32 32w, https://tac.imgix.net/wp-content/uploads/2024/08/TAC_jaddinghs_final.jpg?auto=format&crop=faces%2Centropy&fit=crop&ixlib=php-3.3.1&w=32 32w, https://tac.imgix.net/wp-content/uploads/2024/08/TAC_jaddinghs_final.jpg?auto=format&crop=faces%2Centropy&fit=crop&ixlib=php-3.3.1&w=32 32w,…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The American Conservative.
Discussion
0 commentsMore from The American Conservative
